Oruka Therapeutics Inc. Common Stock vs Telus Corporation Ordinary Shares — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Telus Corporation Ordinary Shares trades at $8.11 (market cap $12.52B). The key difference: Telus Corporation Ordinary Shares is far larger — about 2.4× Oruka Therapeutics Inc. Common Stock's market cap, and Telus Corporation Ordinary Shares pays a 6.59% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Telus Corporation Ordinary Shares for 0 Days on average.
| ORKA | TU | |
|---|---|---|
Market Cap | $5.18B | $12.52B |
Volume | 490,798 | 6,655,034 |
Sector | Health | Media |
52-Week High | $113.08 | $15.33 |
52-Week Low | $26.19 | $7.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $33.57B |
Dividend Yield | — | 6.59% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Telus Corporation is a Canadian telecommunications company providing wireless, internet, television, and business connectivity services, with additional operations in digital healthcare through Telus Health and customer experience services through Telus Digital.
Read more on TU →